Regulatory Edge Opportunity to provide post-market surveillance and regulatory compliance services to reduce safety issues and maintain FDA alignment for Class III devices, leveraging experience from MAUDE concerns and recalls.

Data Driven Care Leverage device telemetry and patient outcomes data to offer data analytics remote monitoring and performance dashboards that can improve LVAD reliability and patient care.

Reimbursement Strategy Payer and reimbursement strategy support to strengthen market access against competitors such as Abbott, including CMS engagement coding optimization and health economic value propositions.

Ecosystem Partnerships Partnerships and ecosystem play with larger OEMs or portfolio expansions, including integration services joint go-to-market and cross-portfolio opportunities leveraging knowledge from Valtechcardio and potential synergies with major device manufacturers.

Global Expansion Global expansion and patient access opportunities through international markets hospital networks and direct-to-payer programs with training and support services to drive adoption of LVAD technologies.